prof. dr. apr. Olivier De Wever
- ORCID iD
-
0000-0002-5453-760X
Show
Sort by
-
- Journal Article
- A1
- open access
Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
-
- Journal Article
- A1
- open access
Benchmarking blood collection tubes and processing intervals for extracellular vesicle performance metrics
-
Performance evaluation of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study
-
- Journal Article
- A1
- open access
Direct lysis of 3D cell cultures for RT-qPCR gene expression quantification
-
Hybrid scaffolds as long-term in vitro co-culture model for targeted treatment of ovarian cancer
-
Preclinical platform for long-term evaluation of drug efficacy using three-dimensional tumor-stroma spheroids embedded in stiffness-tunable scaffolds
-
Hybrid scaffolds to create long-term in vitro co-culture model for targeted treatment of ovarian cancer
-
- Miscellaneous
- open access
Performance evaluation of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study
-
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial
(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188 -
- Conference Paper
- C3
- open access
Single-event ICP-mass spectrometry analysis : faster data acquisition speed opens the way to novel applications